Evogene Ltd.

Regulatory Filings • Jul 22, 2014

_________ false

C002����� ��"�2PublicEVOGENE LTD9756Corporation no: 512838723Stock Exchange/Market: -12369380Gad Feinstein St 13, P.O.B 2100 , Rehovot 76121 , ,Tel: 08-9311900 , Fax: 08-9466724E.mail address: ofer.haviv@evogene.comReported via MAGNA: 22/07/2014              Time of broadcast: 14:03 13:33:20

Company site:		www.evogene.com

Reference: 2014-02-119268

Israel Securities Authority		Tel Aviv Stock Exchange
www.isa.gov.il		www.tase.co.il

Immediate ReportRegulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000

The corporation is a foreign private issuer as defined by U.S. Securities Laws.
Attached hereto is a report on Press Release: Evogene and Marrone Bio Innovations Sign Multi-Year Collaborative Agreement.
6k_EVO_Marrone_isa.pdf

References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
Previous names of reporting entity:
Date of revision of form structure: 14/05/2014
- - -
Name of the Signatory: : Israeli Gaffa Inbal , Position of Signatory in the reporting corporation: Company Secretary , Name of Employer Company: .
Gad Feinstein Telephone: 08-9311900 , Facsimile: 08-9466724 , E-mail: inbalig@evogene.com 1